| Literature DB >> 32495512 |
Chao-Xin Wang1, Zi-da Huang1, Bai-Jian Wu1, Wen-Bo Li1, Xin-Yu Fang1, Wen-Ming Zhang1.
Abstract
Our systematic review compiled multiple studies and evaluated survivorship and clinical outcomes of cup-cage construct usage in the management of massive acetabular bone defects. This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Various combinations of "acetabular", "pelvis", "cup cage" and their corresponding synonyms were used to search relevant articles in the Cochrane, EMBASE, and PubMed databases. Basic information of the functional scores, implant revision rate, and complication rate were selected as outcomes for analysis. Finally, a total of 11 articles published between 1999 and 2019 were selected, which include 232 patients with an average age of 68.5 years (range, 30-90). The mean follow-up period was 48.85 months (range, 1-140). Our study shows that the cup-cage construct has a good clinical outcome with a low revision rate and a low complication rate. Improved clinical outcomes of cup-cage constructs were seen with a revision rate of 8% and an all-cause complication rate of 20%. The most commonly reported complication was dislocation, followed by aseptic loosening, infection, and nerve injuries. In summary, it is a promising method for managing large acetabular bone defects in total hip revision.Entities:
Keywords: Acetabular defect; Bone defects; Cup-cage; Total hip revision
Mesh:
Year: 2020 PMID: 32495512 PMCID: PMC7307242 DOI: 10.1111/os.12710
Source DB: PubMed Journal: Orthop Surg ISSN: 1757-7853 Impact factor: 2.071
Figure 1Flow diagram of the systematic literature search
Study characteristics
| Author | Year | No. of hips | Gender (female/male) | Mean age (years) | Mean follow‐up (years) | Classification (No. of hips) | Revision reason (No. of hips) |
|---|---|---|---|---|---|---|---|
| Suari | 2019 | 22 | 8/14 | 72(40–89) | 45(12–73) | Paprosky type 3A (8), type 3B (14) |
Aseptic loosening (17) Infection (3) Fracture (2) |
| Arvinte | 2019 | 6 | 5/1 | 76(73–81) | 72(63–140) | Paprosky type 3B (7) | Aseptic loosening (6) |
| Hipfl | 2018 | 35 | 7/27 | 70(42–85) | 47(25–84) | Gross type IV (11),type V (25) |
Aseptic loosening (29) Infection (6) |
| Alfaro | 2010 | 5 | 3/2 | 66(61–78) | 19(8–31) | Paprosky type 3B (5) | Aseptic loosening (5) |
| Kellett | 2010 | 14 | NR | 62(45–82) | 27(1–39) | Uncontained bone loss more than 50% in all 14 patients | NR |
| Konan | 2017 | 24 | 17/7 | 72(37–90) | 72(24–120) | Pelvic discontinuity in all 24 patients | NR |
| Martin | 2017 | 27 | NR | NR | 46(25–87) | Pelvic discontinuity in all 27 patients | NR |
| Boscainos | 2007 | 14 | NR | NR | 32(6–45) | No host bone contact with the cup in six patients, less than 40% host bone contact in seven patients | NR |
| Rogers | 2012 | 42 | NR | NR | 35(24–45) | Pelvic discontinuity in all 42 patients | Septic or aseptic periprosthetic bone loss |
| Mu | 2017 | 16 | 6/10 | 62(40–84) | 18(6–36) | Paprosky type 3B (16) |
Aseptic loosening (14) Infection (2) |
| Amenabar | 2015 | 27 | 14/50 | 66(30–86) | 74(24–135) | Gross type IV (26), type V (41) |
Aseptic loosening (59) Infection (7) |
NR, not reported.
Outcome date
| Author | No. of hips | Reoperation for any Reason | Revisions of the construct | Complications | Dislocation | Loosening | Infection | Nerve injuries | Others | Mean functional outcomes |
|---|---|---|---|---|---|---|---|---|---|---|
| Suari | 22 | 3 | 0 | 3 | 2 | 0 | 1 | 0 | 0 |
HHS improved from 30 to 72; MAP score improved from 6.91 to 14.36; |
| Arvinte | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HHS improved from 8 to 36. WOMAC score improved from 76 to 26.5; SF‐12: PCS improved from 24.78 to 40.15; MCS improved from 35.5 to 46.64. |
| Hipfl | 35 | 4 | 3 | 6 | 2 | 0 | 2 | 2 | 0 | NR |
| Alfaro | 5 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | MAP score improved from 4 to 8.8; |
| Kellett | 14 | 1 | 0 | 2 | 1 | 0 | 0 | 0 | Hematoma (1) |
OHS improved from 45 to 28. WOMAC score improved from 64 to 33; SF‐36 improved from 351 to 601. |
| Konan | 24 | 4 | 1 | 4 | 0 | 3 | 1 | 0 | Fracture (1) |
OHS improved to 78.6; WOMAC score improved to 80.2; SF‐36 improved from 351 to 601. |
| Martin | 27 | Unknown | 0 | 7 | 2 | 1 | 1 | 1 | DVT (1) | HHS improved to 66. |
| Boscainos | 14 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | Hematoma (1) |
OHS improved from 45 to 28. WOMAC score improved from 64 to 33; SF‐36 improved from 352 to 601. |
| Rogers | 42 | Unknown | 4 | 13 | 6 | 5 | 1 | 1 | 0 | NR |
| Mu | 16 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | HHS improved from 45.63 to 75.78. |
| Amenabar | 27 | 10 | 4 | 13 | 3 | 4 | 3 | 2 | 0 |
MAP score improved from 6 to 13. |
NR: Not reported; DVT: Deep vein thrombosis; HHS: Harris Hip Score; OHS: Oxford Hip Score; PMA: Postel‐Merle d'Aubigne; WOMAC: Western Ontario and McMaster Universities Arthritis Index; SF‐12: Short‐Form 12, PCS: Physical Component Score, MCS: Mental Component Score; SF‐36: Short‐Form 36.